Inhibition of IGF-1R (using IGF-1R inhibitors NVP-AEW541 or PPP [picropodophyllin]) combined with sorafenib increases apoptosis in hepatocellular carcinoma cells, demonstrating the role of IGF-1R in sorafenib resistance. The gene discussed is IGF1R; the disease is hepatocellular carcinoma.